Rising Demand for Personalized Medicines Drives Pharmaceutical Unit Dose Packaging Market to grow at 14.7% CAGR through 2031

According to a survey by Future Market Insights (FMI), the pharmaceutical unit dose packaging market is anticipated to see a change in how it operates as manufacturers focus on boosting productivity through the integration of automated systems. The market will surpass US$ 26.10 Bn by 2021, recording a double-digit year-over-year (Y-o-Y) growth between 2020 and 2021, according to the analysis.

A type of primary packaging known as unit dosage packaging is the initial tier of containers used to package pharmaceutical medicines. Blisters, vials, ampoules, and prefilled syringe cartridges are some of these.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5236

The demand for pharmaceutical unit dose packaging solutions has been significantly fueled by the growing use of medications as part of treatment prescribed for various ailments and for large vaccination programmes undertaken by leading international organisations such as UNISEF, the World Health Organization (WHO), and others. Sales have increased dramatically as a result of COVID-19 immunisation campaigns and treatment programmes.

Competitive Landscape

(Global Players)

  • Gerresheimer AG
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • SGD SA
  • Stevanato Group S.p.a.
  • Klockner Pentaplast Group
  • UDG Healthcare plc
  • Amcor plc
  • Berry Global, Inc.
  • Comar LLC
  • Constantia Flexibles Group GmbH
  • Nipro Corporation
  • Catalent, Inc.
  • Becton, Dickinson and Company

Ask an Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-5236

Country-wise Insights

Sound Pharmaceutical Base Supports Growth in U.S.

According to the report, the United States is likely to exhibit consistent demand for pharmaceutical unit dose packaging products over the next five years. One of the key aspects supporting market growth is that, the U.S. is the place for most of the top pharmaceutical drugs & medications research and development and manufacturing facilities who specifically deal with new product developments for various diseases.

Johnson & Johnson, Pfizer Inc., AbbVie Inc., Eli Lilly and Company, and many others have their R&D and manufacturing facilities in the U.S. which plays an important role in fuelling sales of pharmaceutical unit dose packaging solutions.

On the other hand, the top suppliers of pharmaceutical unit dose packaging products such as West Pharmaceutical Services, Inc., Berry Global, Inc., Aptar Group, Inc., Becton, Dickinson & Company, and Catalent, Inc. are tirelessly supplying their services to the customers in the U.S.

Report Customization available @ https://www.futuremarketinsights.com/customization-available/rep-gb-5236

Key Takeaways from Pharmaceutical Unit Dose Packaging Market

  • Pharmaceutical unit dose packaging sales will surge at 14.7% CAGR between 2021 and 2031
  • The presence of several leading players has enabled the U.S. account for over 87% of sales in North America in 2021
  • Rising research and development initiatives enabling the U.K. exhibit over 15% y-o-y growth in 2021
  • Surging healthcare spending has been fuelling the demand in Germany and France
  • Increasing demand for vaccination amid COVID-19 fuelling sales in China, Japan, and South Korea

Pharmaceutical unit dose packaging Market by Category

Product:

  • Blisters Pharmaceutical Unit Dose Packaging
  • Ampoules Pharmaceutical Unit Dose Packaging
  • Vials Pharmaceutical Unit Dose Packaging
  • Prefilled Syringes Cartridges

Material:

  • Plastic Pharmaceutical Unit Dose Packaging
    • Polyethylene(PE)
      • High Density Polyethylene (HDPE)
      • Low Density Polyethylene (LDPE)
    • Polypropylene Pharmaceutical Unit Dose Packaging
    • Poly vinyl chloride(PVC) Pharmaceutical Unit Dose Packaging
    • Polyethylene Terephthalate (PET) Pharmaceutical Unit Dose Packaging
  • Aluminum Pharmaceutical Unit Dose Packaging
  • Glass Pharmaceutical Unit Dose Packaging
  • Paper & Paperboard Pharmaceutical Unit Dose Packaging

About Us:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years

Contact Us:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedInTwitterBlogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these